Gossypol (acetic acid) | 醋酸棉酚 | MedChemExpress (MCE)

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Gossypol (acetic acid)

CAS No. : 12542-36-8

MCE 国际站：Gossypol (acetic acid)

产品活性：Gossypol acetic acid ((±)-Gossypol-acetic acid) 分别与 Bcl-xL 蛋白和 Bcl-2 蛋白结合，K_i 值分别为 0.5-0.6 μM 和 0.2-0.3 mM。

研究领域：Apoptosis

作用靶点：Bcl-2 Family

In Vitro: Gossypol, a natural product isolated from cottonseeds and roots that has been studied as an anticancer agent. The racemic form of Gossypol [(±)-Gossypol] is tested in several clinical trials and is well tolerated. The racemic form Gossypol ((±)-Gossypol) binds to Bcl-xL protein with a K_i of 0.5 to 0.6 μM. (±)-Gossypol also potently binds to Bcl-2 protein with a K_i value of 0.2-0.3 mM. The natural racemic Gossypol has two enantiomers, namely the (-)-Gossypol and (+)-Gossypol enantiomers. The racemic form and each of the enantiomers of Gossypol are tested against UM-SCC-6 and UM-SCC-14A in 6-day MTT assays. (-)-Gossypol exhibits greater growth inhibition relative to (±)-Gossypol than (+)-Gossypol in both cell lines tested (P<0.001). An intermediate growth inhibitory effect is observed with (±)-Gossypol but this effect is only observed at the higher dose of Gossypol (10 μM, P<0.0001).

相关产品：Covalent Screening Library Plus  |  Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Phenols Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Blood Cancer Compound Library  |  Mitochondria-Targeted Compound Library  |  Food-Sourced Compound Library   |  Rare Diseases Drug Library  |  Anti-Cancer Natural Product Library  |  Plant-Sourced Natural Product Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Off-patent Drug Library  |  Highly Selective Inhibitors Library  |  FDA-Approved Traditional Chinese Medicine Active Compound Library  |  Anti-Hematopathy Compound Library  |  Anti-Ovarian Cancer Compound Library  |  Multi-Target Compound Library  |  Venetoclax  |  Navitoclax  |  Polyinosinic-polycytidylic acid  |  Sulforaphane  |  S63845  |  ABT-737  |  A-1331852  |  Chlorin e6  |  AZD-5991  |  BT2  |  A-1155463  |  BAI1  |  Estradiol benzoate  |  MIK665  |  Benzbromarone  |  Obatoclax Mesylate  |  Chelerythrine chloride  |  BI-3802  |  AZD4320  |  Amantadine  |  WEHI-539 hydrochloride  |  Dehydrocorydaline  |  Digitoxin  |  Tapotoclax  |  A-1210477  |  Bax inhibitor peptide V5  |  Gambogic Acid  |  DT2216  |  Daphnetin  |  BTSA1

热门产品线：重组蛋白  |  药物筛选  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。